Market closed
Sartorius/SRT3
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Sartorius
Sartorius AG, trading under the ticker symbol SRT3, is a global provider of laboratory and bioprocess technologies, offering products and services that cater to the needs of the biopharmaceutical and research industries. Founded in 1870 and headquartered in Göttingen, Germany, the company specializes in filtration, fermentation, fluid management, and laboratory products, supporting clients ranging from research facilities to large-scale biopharmaceutical manufacturers. Operating internationally, Sartorius is crucial in enabling the development and production of biotech medications and vaccines, solidifying its role as a crucial player in the life sciences and biotechnology sectors.
Ticker
SRT3
Sector
Trading on
XETRA
Industry
Life Sciences Tools and Services
Headquarters
Employees
14,143
Website
Sartorius Metrics
BasicAdvanced
€15B
Market cap
220.13
P/E ratio
€1.13
EPS
0.90
Beta
€0.74
Dividend rate
0.30%
Dividend yield
Price and volume
Market cap
€15B
Beta
0.9
Dividend rate
€0.74
Financial strength
Current ratio
1.906
Quick ratio
0.952
Long term debt to equity
116.035
Total debt to equity
121.341
Dividend payout ratio (TTM)
65.00%
Interest coverage (TTM)
2.36%
Management effectiveness
Return on assets (TTM)
3.43%
Return on equity (TTM)
3.95%
Valuation
Price to earnings (TTM)
220.126
Price to revenue (TTM)
5.139
Price to book
5.7
Price to tangible book (TTM)
-5.54
Price to free cash flow (TTM)
49.029
Dividend yield (TTM)
0.30%
Growth
Revenue change (TTM)
-13.22%
3-year revenue growth (CAGR)
4.73%
3-year dividend per share growth (CAGR)
1.87%
What the Analysts think about Sartorius
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Sartorius stock.
Sartorius Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Sartorius Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Sartorius stock?
Sartorius (SRT3) has a market cap of €15B as of September 15, 2024.
What is the P/E ratio for Sartorius stock?
The price to earnings (P/E) ratio for Sartorius (SRT3) stock is 220.13 as of September 15, 2024.
Does Sartorius stock pay dividends?
Yes, the Sartorius (SRT3) stock pays dividends to shareholders. As of September 15, 2024, the dividend rate is €0.74 and the yield is 0.3%. Sartorius has a payout ratio of 65% on a trailing twelve-month basis.
When is the next Sartorius dividend payment date?
The next Sartorius (SRT3) dividend payment date is unconfirmed.
What is the beta indicator for Sartorius?
Sartorius (SRT3) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.